Trials / Conditions / Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
4 registered clinical trials studyying Antineutrophil Cytoplasmic Antibody-associated Vasculitis — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis NCT07388277 | Marcela V. Maus, M.D.,Ph.D. | Phase 1 / Phase 2 |
| Recruiting | A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) NCT06733935 | Nkarta, Inc. | Phase 1 / Phase 2 |
| Recruiting | A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis NCT06072482 | Amgen | Phase 4 |
| Completed | The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects NCT05702983 | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Phase 1 |